{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:37:33Z","timestamp":1789137453698,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/25\/B\/NZ2\/00414"],"award-info":[{"award-number":["2017\/25\/B\/NZ2\/00414"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.540726","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:56:52Z","timestamp":1603169812000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Proteasome Composition and Activity Changes in Cultured Fibroblasts Derived From Mucopolysaccharidoses Patients and Their Modulation by Genistein"],"prefix":"10.3389","volume":"8","author":[{"given":"Karolina","family":"Pierzynowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estera","family":"Rintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Witkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wieczerzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podlacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.expneurol.2017.06.010","article-title":"Axonal dystrophy in the brain of mice with Sanfilippo syndrome.","volume":"295","author":"Beard","year":"2017","journal-title":"Exp. Neurol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11332","article-title":"Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses.","author":"Brokowska","year":"2020","journal-title":"Cell Biol. Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s10038-019-0662-9","article-title":"Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future.","volume":"64","author":"Chen","year":"2019","journal-title":"J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/diseases5010005","article-title":"Substrate deprivation therapy to reduce glycosaminoglycan synthesis improves aspects of neurological and skeletal pathology in MPS I mice.","volume":"5","author":"Derrick-Roberts","year":"2017","journal-title":"Diseases"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbamcr.2013.03.023","article-title":"Proteasome dynamics.","volume":"1843","author":"Enenkel","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-018-0565-y","article-title":"Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches.","volume":"44","author":"Fraldi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-017-0111-4","article-title":"How close are we to therapies for Sanfilippo disease?","volume":"33","author":"Gaffke","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11275","article-title":"Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases.","author":"Gaffke","year":"2019","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041204","article-title":"Underestimated aspect of mucopolysaccharidosis pathogenesis: global changes in cellular processes revealed by transcriptomic studies.","volume":"21","author":"Gaffke","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses.","volume":"12","author":"Jak\u00f3bkiewicz-Banecka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-16-26","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.","volume":"16","author":"Jak\u00f3bkiewicz-Banecka","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"B12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-2952(03)00414-3","article-title":"Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.","volume":"66","author":"Kazi","year":"2003","journal-title":"Biochem. Pharm."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150850","article-title":"Immune-mediated inflammation may contribute to the pathogenesis of cardiovascular disease in mucopolysaccharidosis type I.","volume":"11","author":"Khalid","year":"2016","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymgme.2013.06.012","article-title":"High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system.","volume":"109","author":"Kim","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"B15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","article-title":"Monitoring activity and inhibition of 26S proteasome with fluorogenic peptide substrates.","volume":"398","author":"Kisselev","year":"2005","journal-title":"Methods Enzymol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-011-9233-2","article-title":"Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.","volume":"26","author":"Kloska","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-153","article-title":"Synthetic genistein derivatives as modulators of glycosaminoglycan storage.","volume":"10","author":"Kloska","year":"2012","journal-title":"J. Transl. Med."},{"key":"B18","first-page":"159","article-title":"Proteasome: a nanomachinery of creative destruction.","volume":"84","author":"Kudriaeva","year":"2019","journal-title":"Biochemistry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/biom4020585","article-title":"Modelling proteasome and proteasome regulator activities.","volume":"4","author":"Liepe","year":"2014","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease.","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/dna.2019.5221","article-title":"Endoplasmic reticulum and lysosomal quality control of four nonsense mutants of iduronate 2-sulfatase linked to Hunter\u2019s syndrome.","volume":"39","author":"Marazza","year":"2020","journal-title":"DNA Cell. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17054","DOI":"10.1074\/jbc.M114.555300","article-title":"The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation.","volume":"289","author":"Moskot","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/ajmg.a.34053","article-title":"Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome.","author":"Muschol","year":"2011","journal-title":"Am. J. Med. Genet. A."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0871-8","article-title":"Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II.","volume":"9","author":"Osaki","year":"2018","journal-title":"Cell Death Dis."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00632-2","article-title":"Reduced free ubiquitin levels and proteasome activity in cultured neurons and brain tissues treated with amyloid beta aggregates.","volume":"13","author":"Park","year":"2020","journal-title":"Mol Brain."},{"key":"B26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11011-018-0214-6","article-title":"Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases.","volume":"33","author":"Pierzynowska","year":"","journal-title":"Metab. Brain Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12017-018-8482-1","article-title":"Correction of Huntington\u2019s disease phenotype by genistein-induced autophagy in the cellular model.","volume":"20","author":"Pierzynowska","year":"","journal-title":"Neuromol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12017-019-08559-1","article-title":"Mucopolysaccharidosis and autophagy: controversies on the contribution of the process to the pathogenesis and possible therapeutic applications.","volume":"22","author":"Pierzynowska","year":"","journal-title":"Neuromol. Med."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031156","article-title":"Genetic base of behavioral disorders in mucopolysaccharidoses: transcriptomic studies.","volume":"21","author":"Pierzynowska","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuropharm.2019.01.030","article-title":"Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer\u2019s disease.","volume":"148","author":"Pierzynowska","year":"2019","journal-title":"Neuropharmacology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093194","article-title":"Transcriptomic changes related to cellular processes with particular emphasis on cell activation in lysosomal storage diseases from the group of mucopolysaccharidoses.","volume":"21","author":"Rintz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.15252\/emmm.201606965","article-title":"Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases.","volume":"9","author":"Sambri","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","article-title":"Gene therapy for mucopolysaccharidoses.","volume":"123","author":"Sawamoto","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"B34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ptr.3342","article-title":"20S proteasome inhibitory activity of flavonoids isolated from Spatholobus suberectus.","volume":"25","author":"Shim","year":"2011","journal-title":"Phytother. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future.","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A practical review of proteasome pharmacology.","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"B37","author":"Tomatsu","year":"2018","journal-title":"Mucopolysaccharidoses Update."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mcn.2009.01.001","article-title":"Enhanced degradation of synaptophysin by the proteasome in mucopolysaccharidosis type IIIB.","volume":"41","author":"Vitry","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"B39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/iub.1007","article-title":"Gene expression-targeted isoflavone therapy.","volume":"64","author":"W\u0229grzyn","year":"2012","journal-title":"IUBMB Life"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2020.540726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:56:56Z","timestamp":1603169816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2020.540726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":39,"alternative-id":["10.3389\/fcell.2020.540726"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.540726","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"article-number":"540726"}}